Characterizing genomic changes in cancer samples
NCI'S GENOMIC CHARACTERIZATION CENTER IDIQ
['FUNDING_OTHER'] · BROAD INSTITUTE, INC. · NIH-10674663
This study is looking at cancer samples to find genetic changes that might help us understand how cancer develops, and it's for anyone interested in learning more about the genetic factors behind cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BROAD INSTITUTE, INC. (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-10674663 on ClinicalTrials.gov |
What this research studies
This research focuses on analyzing cancer specimens to identify genomic alterations that may contribute to malignancies. The Broad Institute will utilize advanced techniques such as whole exome and whole genome sequencing, along with methylation arrays, to examine up to 3650 cancer samples. By ensuring high-quality data through rigorous quality control measures, the research aims to provide valuable insights into the genetic factors associated with cancer. The findings will be made publicly available to support further research and clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who have available tissue samples for genomic analysis.
Not a fit: Patients without a cancer diagnosis or those who do not have accessible tumor samples may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer genetics, potentially informing more effective treatment strategies for patients.
How similar studies have performed: Previous research has successfully utilized genomic characterization approaches to enhance cancer treatment and understanding, indicating a promising avenue for this study.
Where this research is happening
CAMBRIDGE, UNITED STATES
- BROAD INSTITUTE, INC. — CAMBRIDGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GABRIEL, STACY — BROAD INSTITUTE, INC.
- Study coordinator: GABRIEL, STACY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer